GAPDH and liver cancer: To confirm the hepatic origin of these metastatic lesions, we conducted immunohistochemical staining for liver cancer-related markers (ALB and AFP) with human-specific antigens (human GAPDH and human nuclear antigen) in the metastatic lesions (Fig. S2).